What's new

Human medicines European public assessment report (EPAR): Ovaleap, follitropin alfa, Date of authorisation: 27/09/2013, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Ovaleap, follitropin alfa, Date of authorisation: 27/09/2013, Revision: 13, Status: Authorised

May 27, 2025 - 16:15
 0
Human medicines European public assessment report (EPAR): Ovaleap, follitropin alfa, Date of authorisation: 27/09/2013, Revision: 13, Status: Authorised
Human medicines European public assessment report (EPAR): Ovaleap, follitropin alfa, Date of authorisation: 27/09/2013, Revision: 13, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Prevymis, letermovir, ...

Next Article

Human medicines European public assessment report (EPAR): Sorafenib Accord, sora...

Related Posts

ADRA project - information session for veterinary pharmaceutical industry, Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 May 2025, 14:30 (CEST) to 22 May 2025, 16:00 (CEST)

ADRA project - information session for veterinary pharm...

May 15, 2025  0

Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - November 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 November 2025, 11:00 (CET) to 18 November 2025, 12:00 (CET)

Questions and answers clinic on Product Management Serv...

May 15, 2025  0

Human medicines European public assessment report (EPAR): Ebymect, dapagliflozin,metformin, Date of authorisation: 15/11/2015, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR...

May 23, 2025  0